Healthy Clinical Trial
Official title:
Quantification and Repeatability of Responses to Rapid Bilateral Magnetic Stimulation of the Phrenic Nerves
Verified date | March 2024 |
Source | Swiss Federal Institute of Technology |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In this project the quantification and the repeatability of responses to rapid bilateral magnetic stimulation of the phrenic nerves will be investigated in healthy humans.
Status | Active, not recruiting |
Enrollment | 16 |
Est. completion date | December 2027 |
Est. primary completion date | December 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 39 Years |
Eligibility | Inclusion Criteria: - healthy - non-smoking - normal lung function - body mass index: 18.5-29.9 kg/m2 - able to communicate in english - willing to adhere to study rules Exclusion Criteria: - acute illness or chronic conditions of the gastrointestinal tract, and health conditions affecting metabolism, the cardiovascular or the respiratory system, or sleep - intake of medications affecting metabolism, the cardiovascular, the neuromuscular or the respiratory system, or sleep - any metal or electronics inside of the body - presence of cardiac pacemaker, implanted defibrillators or implanted neurostimulators - history of seizures or epilepsy - tatoos on the stimulation sites - previous enrolment in this study - for women: pregnancy, breastfeeding, or intention to become pregnant during the study |
Country | Name | City | State |
---|---|---|---|
Switzerland | Exercise Physiology Lab, Institute of Human Movement Sciences and Sport, ETH Zurich | Zurich | ZH |
Lead Sponsor | Collaborator |
---|---|
Swiss Federal Institute of Technology |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Changes in airflow | Flow will be recorded by a pneumotachometer and averaged over breaths. | Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec. | |
Other | Changes in chest and abdominal movements | Chest and abdominal movements will be assessed using respiratory belt strain transducers. | Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec. | |
Other | Changes in costal diaphragm activity | Costal diaphragm activity will be continuously recorded via a wireless surface electromyography system. | Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec. | |
Other | Head, shoulder and arm accelerations | Head, shoulder and arm movements will be recorded using wireless acceleration sensors attached to the head and arms. | Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec. | |
Other | Body movement | Overall body movement incl. head, shoulder and arm movements will be recorded using a video camera. | Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec. | |
Other | Changes in skin conductance | Skin conductance (µS) will be continuously recorded with electrodes worn on two fingers. | Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec. | |
Other | Changes in heart rate | Heart rate will will be continuously recorded beat by beat (1/min) with electrodes on both wrists and one ankle. | Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec. | |
Other | Changes in blood pressure | Systolic and diastolic blood pressure (mmHg) will be continuously recorded using a non-invasive device. | Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec. | |
Other | Perception of pain, paresthesia and discomfort | Participant subject perception of pain, paresthesia and discomfort will be evaluated with 0-to-10-point scale, with 0 = no pain/paresthesia/discomfort and 10 = maximal pain/paresthesia/discomfort. Higher values indicate more perception of the specified sensations. | Assessed 10 sec after each stimulation. One stimulation lasts for approx. 1 sec. | |
Primary | Diaphragm contractility | Transdiaphragmatic pressure changes, i.e. changes in esophageal and gastric pressures, will be measured by a pressure transducer connected to balloon-catheters. | Continuously measured from 10 sec before until 10 sec after each stimulation. One stimulation lasts for approx. 1 sec |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |